Labshake search
Citations for Tocris :
351 - 400 of 582 citations for 6 Chloro 4 iodo 3 pyridinol since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... 0,2 4-methoxy-7-nitroindolinyl (MNI)-caged glutamate (Tocris Bioscience), 0,005 CPP [()-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid] (NMDA receptors antagonist ...
-
bioRxiv - Neuroscience 2024Quote: ... NE-100 (CAS#:149409-57-4) was purchased from Tocris Bioscience (Ellisville MO) ...
-
bioRxiv - Neuroscience 2021Quote: ... In every animal a volume of 500nl of CNO (3 µM, Tocris) was infused at a rate of 0.5µl/min to target the PAG ...
-
bioRxiv - Genomics 2020Quote: ... ‘‘CBRa’’ medium consists of cSFDM base supplemented with 3 µM CHIR99021 (Tocris), 10 ng/mL recombinant human BMP4 (rhBMP4 ...
-
bioRxiv - Neuroscience 2021Quote: ... we added the CB1 receptor antagonist AM-251 (3 µM; Tocris, UK), or the NO synthase inhibitor L-NAME (200 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Neuroscience 2020Quote: ... the IS was supplemented with 3 mg/ml biocytin (Tocris, Bristol, UK) or 1.5 mg/ml neurobiotin (Vector Laboratories ...
-
bioRxiv - Genomics 2019Quote: ... and 12 uM of the GSK-3 inhibitor CHIR99021 trihydrochloride (Tocris, 4953). This medium was changed to base heart media 24 hours later (Day 1) ...
-
bioRxiv - Genomics 2021Quote: ... and 12uM of GSK-3 inhibitor CHIR99021 trihydrochloride (4953, Tocris, Bristol, UK). “Heart media” is composed of RPMI (15-040-CM ...
-
bioRxiv - Neuroscience 2022Quote: ... 3 dpf zebrafish were paralysed using α-bungarotoxin (1 mg/ml, Tocris) and embedded in 1.2% low melting point agarose ...
-
bioRxiv - Neuroscience 2022Quote: ... and 3-Deazaneplanocin A hydrochloride (DZN; 1 µg/dose in DMSO; Tocris). Tamoxifen (Sigma ...
-
bioRxiv - Neuroscience 2023Quote: ... Antagonists included the GABA-A blocker bicuculline methiodide (BCC, 3 μM, Tocris) by itself or ...
-
bioRxiv - Cell Biology 2023Quote: ... Media was then changed to cSFDM with 3 uM CHIR99021 (“C”; Tocris), recombinant human BMP4 (10 ng/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... A83-01 (PeproTech, cat# 9094360 or Tocris, cat# 2939, 0.1-3 µM) and the impedance of monolayers was measured at 10 kHz at every 5 min for 48-96 h ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 μM of 2,3-dihydroxy 6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX, 1044, Tocris Bioscience, UK), 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were split 12–30 h after transfection and plated on glass coverslips in the presence of 50 μM NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; Tocris Bioscience) to avoid AMPAR-mediated toxicity ...
-
bioRxiv - Neuroscience 2023Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience) in ACSF at 31-33°C as previously (18) ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Developmental Biology 2021Quote: ... which consists of a N2B27 basal medium supplemented with 3 µM CHIR99021 (Tocris), 1µM PD0325901 (SelleckChem ...
-
bioRxiv - Cancer Biology 2020Quote: ... established tumorspheres were treated with either 0.5 µM or 3 µM CHIR99021 (Tocris) for 5 days ...
-
bioRxiv - Neuroscience 2021Quote: ... The craniotomy was then covered with 3% agar (MilliporeSigma) dissolved in aCSF (TOCRIS). The agar was prevented from drying out by covering it with silicone oil ...
-
bioRxiv - Neuroscience 2021Quote: ... hiPSCs were pretreated for 5 days with 3 μM SB431542 (Tocris, Bristol, UK), 3 μM dorsomorphin (Sigma Aldrich) ...
-
bioRxiv - Cancer Biology 2022Quote: ... 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... The craniotomy was then covered with 3% agar (MilliporeSigma) dissolved in aCSF (TOCRIS). The agar was covered with silicone oil (60,000 centistokes ...
-
bioRxiv - Developmental Biology 2024Quote: ... This CBRa media consists of cSFDM containing 3 μm CHIR99021 (Tocris, No.4423), 10 ng/mL rhBMP4 (R&D ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with Y-27632 (Tocris, cat# 1254, 5 µM, 24 h, day –3). On days 0 and 1 ...
-
bioRxiv - Neuroscience 2021Quote: ... 4- aminopyridine (Tocris Bioscience, 50 µM, 5 min-2hrs or 20hrs), AP5 (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... and the aquaporin-4 channel inhibitor TGN-020 (Tocris; 100 μM) were co-applied (n=16) ...
-
bioRxiv - Physiology 2021Quote: ... and/or 4) 100 nM ONO-8130 (Tocris Bioscience, Bristol, UK). In the latter two conditions ...
-
bioRxiv - Neuroscience 2023Quote: ... and 1 mM (S)-α-methyl-4-carboxyphenylglycine ((S)-MCPG) (Tocris). Neurons were field stimulated with 1 ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 µM CGP54626 Hydrochloride (1088/10, TOCRIS, CAS 149184-21-4), 200 µM (low dose ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Immunology 2021Quote: ... cells were stimulated with HDM or the known AhR agonist FICZ (5,11-Dihydroindolo[3,2-b]carbazole-6-carboxaldehyde, Tocris Bioscience ...
-
bioRxiv - Molecular Biology 2021Quote: ... culture medium was replaced by E6 medium supplemented with 6 μM CHIR (Tocris, Bio-Techne, Abingdon, United Kingdom) to initiate differentiation (defined as day 0) ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.
-
bioRxiv - Physiology 2023Quote: ... animals either received vehicle (1 µl DMSO; n = 6) or the DREADD ligand clozapine n-oxide (CNO, Tocris; 0.1 mg/µl DMSO ...
-
bioRxiv - Cancer Biology 2021Quote: ... the positive control consisted of a treatment with 1 μM 3-AP (#2251; Tocris) for 72 h.
-
bioRxiv - Molecular Biology 2020Quote: Wild type zebrafish were exposed to 3 μM JWH-018 (Tocris, Cat. No. 1342), from 24 hours to six days post fertilization (dpf) ...
-
bioRxiv - Developmental Biology 2023Quote: ... but on day 3 medium was changed for LY (1 µM LPA (Tocris, 3854) and 10 µM ROCKi Y27632 ...
-
bioRxiv - Cell Biology 2023Quote: ... For the next 3 days CDBM with 0,6U/ml heparin and 3mM IWP2 (Tocris) was refreshed daily ...
-
bioRxiv - Neuroscience 2023Quote: ... mice were intraperitoneally injected with either 3 mg per kg of scopolamine hydrobromide (Tocris) dissolved in saline or vehicle (saline) ...
-
bioRxiv - Neuroscience 2021Quote: ... The resulting cell pellet was broken up and resuspended in 1ml E8 media by 1000ul pipette and distributed on a Geltrex coated 6 well plate with E8 and 10µM ROCK inhibitor (Y-27632 dihydrochloride, Tocris) for 24 hours ...
-
bioRxiv - Neuroscience 2020Quote: ... and re-plated at 1:6 ratio on Matrigel-coated plate in neural medium supplemented with 1μM CHIR99021 (Tocris), 2μM DMH1 (Tocris) ...
-
bioRxiv - Neuroscience 2020Quote: ... and re-plated at 1:6 ratio on Matrigel-coated plate in neural medium supplemented with 3μM CHIR99021 (Tocris), 2μM DMH1 (Tocris) ...
-
bioRxiv - Cell Biology 2021Quote: ... or the AMPA-iGluR specific inhibitor 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, cat. num. 373, Tocris). Drugs were dissolved in ESC complete media (no 2i ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience, Bristol, UK). Inhibitors were applied concomitantly from 30 min before to 30 min after DHPG/MPEP treatment ...